Managing CV risk in people with T2D – a practical approach
This content has been independently produced by ADG, made possible through sponsorship from Eli Lilly.
Watch leading endocrinologists A/Prof Roger Chen and A/Prof Samantha Hocking in discussion with GP moderator Dr Jon Fogarty as they help GPs navigate the complex waters of cardiovascular risk management in type 2 diabetes.
The panel discusses the changing treatment landscape and offers practical advice for everyday practice, including an overview of changing guidelines, the evidence for certain drug classes in managing CV risk, and case studies.
A/Prof Roger Chen, Senior Staff Specialist in Endocrinology at St Vincent’s Hospital, Sydney, and Visiting Scientist at the Garvan Institute of Medical Research, discusses management considerations for a patient with established CV disease.
